Argent BioPharma Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Argent BioPharma Limited generated cash of -$7,736,830, which is less than the previous year. Cash used in financing activities reached the amount of $8,055,448 last year. Net change in cash is therefore $463,049.
Cash Flow
| 2016 | -1.80M | -364.76K | 6.35M |
|---|---|---|---|
| 2018 | -3.30M | -190.98K | 2.63M |
| 2020 | -5.54M | -540.19K | 5.82M |
| 2023 | 0 | 606.19K | 9.73M |
| 2024 | -7.73M | -140.12K | 8.05M |
RGT.L Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 239.82K | 1.88M | 1.30M | 6.70M | 213.85K |
Operating activities | |||||
Net income | 0 | 0 | -10.78M | -4.62M | -3.45M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 0 | 267.97K | 183.99K | 993.21K |
Stock-based compensation expense | 0 | 0 | 476.16K | 601.53K | 0 |
| Deferred income tax benefit | 0 | 0 | 476.16K | 601.53K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 151.44K | -178.92K | -220.64K |
Inventories | 0 | 0 | -146.72K | -114.64K | -87.99K |
Accounts payable | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -7.73M | 0 | -5.54M | -3.30M | -1.80M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -140.12K | -189.87K | -535.85K | -257.64K | -138.92K |
Acquisitions Net | 0 | 0 | 0 | 0 | -207.10K |
Cash generated by investing activities | -140.12K | 606.19K | -540.19K | -190.98K | -364.76K |
Financing activities | |||||
Common Stock Issued | 15.70M | 3.08M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -317.83K | 0 | 0 | 0 |
Repayments of term debt | 0 | 7.16M | -102.26K | 0 | 451.08K |
Cash used in financing activities | 8.05M | 9.73M | 5.82M | 2.63M | 6.35M |
Net Change In Cash | 463.04K | -1.64M | -257.99K | -1.17M | 4.21M |
Cash at end of period | 702.87K | 239.82K | 1.04M | 5.52M | 4.42M |
| Data source | Data source | Data source | Data source | Data source |